Science at warp speed: Medical research, publication, and translation during the COVID-19 pandemic
In response to the COVID-19 pandemic, there has been a rapid growth in research focused
on develo** vaccines and therapies. In this context, the need for speed is taken for …
on develo** vaccines and therapies. In this context, the need for speed is taken for …
[PDF][PDF] An overview of the epidemiologic, diagnostic and treatment approaches of COVID-19: what do we know?
Background: In late December 2019, a new infectious respiratory disease (COVID-19) was
reported in a number of patients with a history of exposure to the Huanan seafood market in …
reported in a number of patients with a history of exposure to the Huanan seafood market in …
A false promise of COVID-19 'big'health data? Health data integrity and the ethics and realities of Australia's health information management practice
K Robinson - Health Information Management Journal, 2021 - journals.sagepub.com
Context: Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented volume of medical …
coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented volume of medical …
The fragility of scientific rigour and integrity in “sped up science”: Research misconduct, bias, and hype and in the COVID-19 pandemic
During the early years of the COVID-19 pandemic, preclinical and clinical research were
sped up and scaled up in both the public and private sectors and in partnerships between …
sped up and scaled up in both the public and private sectors and in partnerships between …
Balancing scientific rigor with urgency in the coronavirus disease 2019 pandemic
Balancing Scientific Rigor With Urgency in the Coronavirus Disease 2019 Pandemic | Open
Forum Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford …
Forum Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford …
[HTML][HTML] “Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience”, a retrospective study-original article
Background The first case of Infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was diagnosed in Wuhan, China in 2019. In the first half of 2020, this disease …
(SARS-CoV-2) was diagnosed in Wuhan, China in 2019. In the first half of 2020, this disease …
[PDF][PDF] The rationale for low-molecular weight heparin (LMWH) use in SARS-CoV-2 infection
G Di Perri - Infez Med, 2020 - infezmed.it
SUMMARY Macrophage Activation Syndrome (MAS) have been described, and therapeutic
options other than anti-infective have been proposed and implemented, such as anti …
options other than anti-infective have been proposed and implemented, such as anti …
Evidence-based medicine in ophthalmic journals during covid-19 pandemic
E Walter, O Saban, A Jotkowitz, T Batash… - Clinical …, 2020 - Taylor & Francis
Background COVID-19 has erupted into our lives and forced rapid changes in all fields of
medicine, causing a rush for publications that inevitably caused a shift away from the …
medicine, causing a rush for publications that inevitably caused a shift away from the …
[HTML][HTML] What Do the Data Say?–Traps to Avoid
J Maindonald - bookdown.org
This booklet has as its intended audience, as well as practising researchers, anyone
interested in using data as a basis for judgment. The critical processes and skills that are …
interested in using data as a basis for judgment. The critical processes and skills that are …
An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?
M Ebrahimi Kalan, M Morteza, A Ebrahimi-Kalan… - 2021 - digitalcommons.fiu.edu
Background: In late December 2019, a new infectious respiratory disease (COVID-19) was
reported in a number of patients with a history of exposure to the Huanan seafood market in …
reported in a number of patients with a history of exposure to the Huanan seafood market in …